Bell Kenz Pharma Inc is a Filipino pharmaceutical company headquartered at Bell-Kenz Tower in Quezon City, engaged in the distribution and marketing of prescription and over-the-counter medicines. Established in 2006, the company focuses on providing reasonably priced, high-quality pharmaceutical products to help patients manage treatment costs, with a portfolio that includes cardiovascular medicines, antiplatelet combinations, respiratory therapies such as bronchodilator combinations, and other specialty and general medicines sourced from certified cGMP-compliant manufacturers. Bell Kenz operates as a drug wholesaler and distributor, supplying hospitals, clinics, pharmacies, and medical professionals nationwide, supported by a field force that promotes ethical products and a growing range of nutraceutical and wellness brands. The company also invests in health advocacy and community programs through initiatives like Barangay BK, which aim to improve healthcare access and education in underserved communities. Key assets include its strong relationships with healthcare professionals, compliant distribution infrastructure, and a focused product portfolio addressing prevalent chronic and acute conditions in the Philippines. Strategically, Bell Kenz Pharma Inc positions itself as a leading home-grown pharmaceutical player committed to shaping Filipino healthcare by combining accessible pricing, robust quality standards, and partnership-driven engagement with stakeholders.
Legal Address
6th Floor Bellkenz Tower, 127 Malakas Street, Quezon City
Quezon City; National Capital Region;
Postal Code: 1100
Contact Details: Purchase the Bell Kenz Pharma Inc report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service